ES2099746T3 - Metodo de deteccion y/o dosificacion de hormonas. - Google Patents

Metodo de deteccion y/o dosificacion de hormonas.

Info

Publication number
ES2099746T3
ES2099746T3 ES91910511T ES91910511T ES2099746T3 ES 2099746 T3 ES2099746 T3 ES 2099746T3 ES 91910511 T ES91910511 T ES 91910511T ES 91910511 T ES91910511 T ES 91910511T ES 2099746 T3 ES2099746 T3 ES 2099746T3
Authority
ES
Spain
Prior art keywords
hormones
detection
dosage
antibodies
different
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91910511T
Other languages
English (en)
Inventor
Marie-Christine Maurel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Institut National de la Recherche Agronomique INRA
Original Assignee
Centre National de la Recherche Scientifique CNRS
Institut National de la Recherche Agronomique INRA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Institut National de la Recherche Agronomique INRA filed Critical Centre National de la Recherche Scientifique CNRS
Application granted granted Critical
Publication of ES2099746T3 publication Critical patent/ES2099746T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/963—Methods of stopping an enzyme reaction or stabilizing the test materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/967—Standards, controls, materials, e.g. validation studies, buffer systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Radar Systems Or Details Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

METODO DE DETECCION Y/O DE DOSIFICACION DE LAS HORMONAS INCLUSO LAS HORMONAS PLACENTARIAS Y DE LOS ANTICUERPOS UTILIZABLES EN DICHO METODO DE DETECCION. ESTE METODO, QUE AUMENTA LA SENSIBILIDAD Y LA ESPECIFICIDAD DE LA DETECCION Y/O DE LA DOSIFICACION INMUNOLOGICA DE HORMONAS HUMANAS O ANIMALES EN MEDIOS DE CULTIVO O EN FLUIDOS BIOLOGICOS, QUE APLICA AL MENOS DOS ANTICUERPOS IDENTICOS O DIFERENTES, ESPECIFICOS DE LA HORMONA A DOSIFICAR, SE CARACTERIZA EN QUE AL MENOS UNO DE DICHOS ANTICUERPOS ESTA PREINCUBADO EN UN MEDIO QUE CONTIENE PLASMA O SUERO DESPROVISTO DE LA HORMONA A DETECTAR Y/O A DOSIFICAR (MEDIO INC)
ES91910511T 1990-06-01 1991-05-30 Metodo de deteccion y/o dosificacion de hormonas. Expired - Lifetime ES2099746T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9006863A FR2662804B1 (fr) 1990-06-01 1990-06-01 Anticorps polyclonaux anti-lh et leurs applications a la detection et/ou au dosage de la lh, chez de multiples especes animales.

Publications (1)

Publication Number Publication Date
ES2099746T3 true ES2099746T3 (es) 1997-06-01

Family

ID=9397207

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91910511T Expired - Lifetime ES2099746T3 (es) 1990-06-01 1991-05-30 Metodo de deteccion y/o dosificacion de hormonas.

Country Status (13)

Country Link
US (1) US5674700A (es)
EP (1) EP0533719B1 (es)
AT (1) ATE148562T1 (es)
AU (1) AU7958091A (es)
DE (1) DE69124511T2 (es)
DK (1) DK0533719T3 (es)
ES (1) ES2099746T3 (es)
FR (1) FR2662804B1 (es)
IE (1) IE911894A1 (es)
NZ (1) NZ238394A (es)
PT (1) PT97839B (es)
WO (1) WO1991019195A2 (es)
ZA (1) ZA914121B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3479100B2 (ja) * 1993-06-02 2003-12-15 帝国臓器製薬株式会社 免疫化学的簡易半定量方法および装置
AU7146198A (en) * 1997-04-23 1998-11-13 Richard J Harrison Method for fertility detection
US20010023070A1 (en) * 1998-05-29 2001-09-20 Reinhard Ebner Interleukins-21 and 22
EP1143249B1 (en) * 2000-04-03 2014-01-15 Alere Switzerland GmbH Test methods and devices for analyte isoforms
EP1143250A3 (en) * 2000-04-03 2004-11-17 Inverness Medical Switzerland GmbH Test methods and devices for analyte isoforms
JP2001349892A (ja) * 2000-04-03 2001-12-21 Unilever Nv 検査方法及びデバイス
US7297354B2 (en) * 2000-04-26 2007-11-20 Land O'lakes, Inc. Protein material
US8592219B2 (en) * 2005-01-17 2013-11-26 Gyros Patent Ab Protecting agent
WO2006076371A2 (en) * 2005-01-10 2006-07-20 Baylor College Of Medicine Method of quantitative immunohistochemistry and in situ hybridization
EP1849004A1 (en) * 2005-01-17 2007-10-31 Gyros Patent Ab A versatile flow path
US9970897B2 (en) 2008-06-16 2018-05-15 Duke University Chemical sensors and methods for making and using the same
US9958442B2 (en) * 2009-02-11 2018-05-01 Duke University Sensors incorporating antibodies and methods of making and using the same
CN102297966A (zh) * 2011-05-27 2011-12-28 天津农学院 一种半定量检测孕酮胶体金试纸条及其制备方法
WO2013153291A1 (fr) 2012-04-12 2013-10-17 Repropharm Procede et trousse de detection du pic preovulatoire de lh
EP3107569A4 (en) 2014-02-20 2018-02-21 Alder Biopharmaceuticals, Inc. Anti-acth antibodies and use thereof
WO2015187227A2 (en) 2014-03-13 2015-12-10 Duke University Electronic platform for sensing and control of electrochemical reactions
CN105445256A (zh) * 2014-09-02 2016-03-30 江苏泽成生物技术有限公司 促黄体生成素lh定量测定试剂盒及其制备方法与检测方法
CN105424937B (zh) * 2015-10-05 2017-11-21 华中农业大学 一种猴早期妊娠检测的孕酮胶体金免疫层析试纸条
JP6959883B2 (ja) * 2018-02-28 2021-11-05 株式会社あすか製薬メディカル オキシトシンの定量方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991174A (en) * 1970-07-20 1976-11-09 Rafa Laboratories Ltd. Method of determining concentration of luteinizing hormone in body fluid
US4002532A (en) * 1974-10-21 1977-01-11 Weltman Joel K Enzyme conjugates
NO753203L (es) * 1974-11-11 1976-07-21 Carter Wallace
US4559145A (en) * 1982-06-16 1985-12-17 Amf Incorporated Process for preparing a zero standard serum
DE3225027A1 (de) * 1982-07-05 1984-01-05 Boehringer Mannheim Gmbh, 6800 Mannheim Immunchemisches messverfahren
DE3507848A1 (de) * 1985-03-06 1986-11-13 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und reagenz zur bestimmung des luteinisierenden hormons sowie hierzu geeignete monoklonale antikoerper
US4935147A (en) * 1985-12-20 1990-06-19 Syntex (U.S.A.) Inc. Particle separation method

Also Published As

Publication number Publication date
PT97839B (pt) 1998-10-30
DE69124511D1 (de) 1997-03-13
ATE148562T1 (de) 1997-02-15
WO1991019195A3 (fr) 1992-01-09
ZA914121B (en) 1992-03-25
DK0533719T3 (da) 1997-08-11
AU7958091A (en) 1991-12-31
US5674700A (en) 1997-10-07
EP0533719B1 (fr) 1997-01-29
NZ238394A (en) 1993-04-28
WO1991019195A2 (fr) 1991-12-12
FR2662804B1 (fr) 1994-05-27
EP0533719A1 (fr) 1993-03-31
FR2662804A1 (fr) 1991-12-06
DE69124511T2 (de) 1997-07-31
PT97839A (pt) 1992-02-28
IE911894A1 (en) 1991-12-04

Similar Documents

Publication Publication Date Title
NO973444L (no) Fremgangsmåter og forbindelser for magnetrelaksometrisk påvisning av analytter, samt anvendelse av slike
ES2038381T3 (es) Dispositivo para la realizacion de analisis biologicos por deteccion inmuno-enzimatica de anticuerpos o de antigenos en suero.
DE69230890D1 (de) Bestimmung von nukleären matrixproteinen in flüssigkeiten
DK0988534T3 (da) Elektroniske fremgangsmåder og apparat til detektering af analytter
WO1991019195A3 (fr) Methode de detection et/ou de dosage des hormones et anticorps utilisables dans ladite methode de detection
ATE357663T1 (de) Teilchenförmiges markierungsmittel verwendendes analytassay
DE69212172D1 (de) Messfühler zur Detektion chemischer Substanzen oder von Photonen unter Benutzung eines Feldeffekttransistors
ATE175233T1 (de) Vorrichtung zur überwachung von flussigkeiten
DE3872754D1 (de) Nachweis von antikoerpern humaner immundefizienz-viren.
ES2139571T3 (es) Ensayo de hepatitis c que utiliza antigenos recombinantes.
DE69023476D1 (de) Mehrschicht-Testvorrichtung zur Bestimmung von Substanzen in Flüssigkeiten.
DE68926594D1 (de) Ultraschallvorrichtung zur Feststellung von Fehlstellen
AU1259801A (en) Detection method by pcr
DE69230917D1 (de) Verfahren zur detektion von hepatitis c
DE69120088D1 (de) Vorrichtung zur feststellung des dampfdruckes von flüssigkeiten
IT8921788A0 (it) Reattivo utile per la rilevazione e la determinazione quantitativa dei leucociti in fluidi biologici.
ES2186121T3 (es) Mejora de los resultados de los dosificados de inmunodeteccion gracias al empleo de varios trazadores.
CY1106349T1 (el) Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c
DK0643830T3 (da) Fremgangsmåde til detektering af gastrisk epitelbeskadigelse
FI910324A7 (fi) Menetelmät ja testipakkaukset ihmisen leukosyyttiantigeeni-DNA:n havaitsemiseksi
EP0571536A4 (en) REAGENTS AND METHODS FOR IDENTIFYING VACCINES.
NL191957C (nl) Dosimeter voor het aantonen van gasvormige of in vloeistoffen opgeloste stoffen.
DE69606024D1 (de) Feststellung von antikörperproduktion
FI910999A7 (fi) Menetelmä ja laite aineiden vuorovaikutusten tutkimiseksi ja määrittämiseksi biologisilla soluilla
ATE160448T1 (de) Nachweis von thrombopenies

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 533719

Country of ref document: ES